International Conference on Structural Biology and Drug Design (ICSBDD - 26)

This track focuses on the latest methodologies and technologies in protein crystallography, emphasizing their applications in drug design. Participants will explore case studies that highlight the impact of high-resolution structures on understanding protein function.

This session will delve into cutting-edge molecular modeling and simulation approaches used to predict protein-ligand interactions. Discussions will include advancements in computational techniques that enhance the accuracy of molecular dynamics simulations.

This track will examine the intricate relationships between enzyme structures and their catalytic functions. Researchers will present findings that elucidate how structural variations influence enzyme activity and specificity.

This session will cover innovative computational docking strategies that facilitate the identification of potential drug candidates. Emphasis will be placed on the integration of docking algorithms with experimental data to enhance predictive power.

This track focuses on the structural analysis of macromolecular complexes, including protein-protein and protein-nucleic acid interactions. Participants will discuss techniques such as cryo-electron microscopy and X-ray crystallography that provide insights into complex formation.

This session will highlight the role of NMR spectroscopy in elucidating the structures of biomolecules in solution. Researchers will present novel applications of NMR in studying protein dynamics and conformational changes.

This track will explore methodologies for binding site analysis and their implications for rational drug design. Attendees will learn about computational tools that assist in identifying and characterizing druggable sites on target proteins.

This session will focus on the engineering of proteins for therapeutic purposes, including the design of enzyme inhibitors and biologics. Discussions will cover strategies for optimizing protein stability and activity.

This track will examine the intersection of medicinal chemistry and structural biology, emphasizing how structural insights inform the design of novel therapeutics. Participants will share case studies that illustrate successful collaborations between chemists and structural biologists.

This session will present various strategies employed in rational drug design, showcasing successful case studies that led to the development of new therapeutics. Emphasis will be placed on the integration of structural data into the drug discovery process.

This track will investigate the mechanisms underlying protein-ligand interactions and their relevance to drug efficacy. Participants will discuss experimental and computational approaches to studying these interactions in detail.